arrow
M

Misook Choe

walter reed army institute of research
H指数:28
被引数:3,750

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Production of Clinical-Grade SARS-CoV-2 Spike Ferritin Nanoparticle Protein Immunogen by Transient Transfection

通过瞬时转染生产临床级SARS-CoV-2 Spike Ferritin Nanoparticle Protein免疫原

2026-03-030
OAAI
Antibody sequence determinants of viral antigen specificity
MBIO
IF4.7
2024-10-161
OAAI
A multispecific antibody against SARS-CoV-2 prevents immune escape in vitro and confers prophylactic protection in vivo
2024-10-090
PRE
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challenge
2024-01-173
PRE
Extraordinary Titer and Broad Anti-SARS-CoV-2 Neutralization Induced by Stabilized RBD Nanoparticles from Strain BA.5
2023-12-284
OAAI
Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery
2023-08-084
OAAI
Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes
2023-08-017
OAAI
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
2023-07-2712
OAAI
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
2023-02-0316
OAAI
Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition
IMMUNITY
IF26.3
2022-11-0115
OAAI
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model
2022-05-0420
OAAI
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
2022-05-01281
OAAI
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial
2022-04-1147
OA
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates
2022-02-1694
OA
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
2021-12-01114
OAAI
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations
2021-10-2942
OAAI
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
2021-09-0143
OAAI